Title
Antithrombotic Therapy For Atrial Fibrillation
Authoring Organization
Publication Month/Year
August 1, 2018
Last Updated Month/Year
January 23, 2024
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical benefit for patients with AF at varying levels of stroke risk and in a number of common clinical scenarios.
Target Patient Population
Patients with atrial fibrillation
Inclusion Criteria
Female, Male, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Long term care, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Prevention, Management, Treatment
Diseases/Conditions (MeSH)
D001281 - Atrial Fibrillation, D011315 - Preventive Medicine, D020521 - Stroke, D011655 - Pulmonary Embolism, D012307 - Risk Factors
Keywords
atrial fibrillation, risk factors, prevention, anticoagulation, stroke, Stroke Prevention, Antithrombotic Agents, Anticoagulation